Antimicrobial wound Dressings. (Product Spotlight).

Coloplast Corp. has announced that Contreet[R] Hydrocolloid, Non-Adhesive Foam, and Adhesive Foam Antimicrobial Barrier Dressings have been cleared by the U.S. Food and Drug Administration (FDA).

Contreet Antimicrobial Barrier Dressings are indicated for chronic and acute wounds, specifically leg ulcers and pressure sores. These dressings can also be used for partial-thickness burns, donor sites, postoperative wounds, and skin abrasions. In addition, the Contreet dressings are indicated in wounds that are colonized, infected, or at risk of infection.

Contreet belongs to a new generation of antibacterial dressings based on hydroactivated ionic silver technology. The ionic silver is liberated from its carrier during an exchange with the sodium and potassium ions normally found in wound exudate. Contreet dressings demonstrate in-vitro antibacterial barrier activity for up to seven days in bacterial strains known to be detrimental to wound healing.

Contreet Hydrocolloid, introduced in January 2003, was the first wound dressing to combine a hydrocolloid with an antibacterial ionic silver complex dispersed throughout the dressing. Both Contreet Hydrocolloid and Contreet Adhesive foam incorporate the advantages of moist wound healing with sustained antibacterial activity, effective exudate management, moisture control for optimal wound healing, and a physical barrier against airborne contamination into one easy-to-use dressing. Contreet offers the advantage of silver technology without the need for lengthy preparation or a secondary dressing.

CIRCLE 61 ON READER SERVICE CARD